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Abstract
Background: Nerve conduction studies are an objective, quantitative, and reproducible measure of peripheral
nerve function and are widely used in the diagnosis of neuropathies. The purpose of this study is to determine
the reliability of nerve conduction parameters derived entirely from computer based data acquisition and
waveform cursor assignments and to quantify the relative contributions of test variability sources.
Methods: Thirty volunteers, some with symptoms suggestive of neuropathies; of these, 29 completed the study.
The median, ulnar, deep peroneal, posterior tibial, and sural nerves were evaluated bilaterally at two test sessions
3-7 days apart. Within each session, nerves were tested twice within 10 minutes. The analyzed nerve conduction
parameters include motor latencies, motor conduction velocity (CV), compound muscle action potential (CMAP)
amplitude, F-wave latencies (minimum, mean and maximum), sensory peak latency (DSL), sensory CV, and
sensory nerve action potential (SNAP) amplitude. The primary outcome measure is variance component analysis
and the corresponding coefficient of variation (CoV). The between-session-test variance is the sum of within-
session variance and between-session variance, quantifying the total variation between test sessions. Additional
statistical measures include the intraclass correlation coefficient (ICC) and relative interval variation (RIV).
Results: Motor and sensory latencies, CV and F-wave latency parameters have low between-session-test CoVs,
ranging from 4.2% to 9.8%. Amplitude parameters have a higher between-session-test CoVs in the range of 15.6-
-19.8%. Between-test CoVs are about 30--80% lower than between-session CoVs with the exception of F-wave
latency parameters. Between-test ICC values are 0.96 or above for all parameters. Between-session ICC ranges
from 0.98 for F-wave latency to 0.77 for sural sensory CV. All latency-related between-session ICCs have a value
0.83 or above. The RIVs are the tightest for F-wave latency parameters and widest for CMAP amplitude
parameters. Repeatability in a sub-group of subjects with more severe symptom grades follows the same trend
as the overall study population without substantial quantitative differences.
Conclusion: The study demonstrates the high repeatability of nerve conduction parameters acquired by modern
electrodiagnostic instruments using computer based waveform cursor assignment. The reliability is comparable
to benchmark studies in which the nerve conduction measurements were performed manually in controlled
multi-center clinical trials. Furthermore, the ranking of reliability, whereby F-wave latencies have the best
reproducibility and amplitudes the worst, is also consistent with the benchmark studies.
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Background
Nerve conduction studies (NCS) are an objective, quanti-
tative, and reproducible measure of peripheral nerve func-
tion and are widely used in the diagnosis of neuropathies
[1]. They have also been used to monitor neuropathic dis-
ease progression [2] and the efficacy of interventions in
clinical trials [3,4]. Several sources of test variability may
degrade NCS measurement repeatability. They include the
use of disparate equipment at different test sessions or
sites [5], inconsistent placement of recording and stimu-
lating electrodes [6], use of non-standardized distance
measurements, differences or errors in waveform cursor
assignments, use of sub-maximal electrical stimuli, poor
skin preparation resulting in high skin impedance, and
failure to either maintain limb temperature within an
acceptable range or to compensate for temperature devia-
tions. All these factors may compromise repeatability and
lead to inaccurate diagnostic conclusions.
Aside from inherent physiological changes, factors that
influence repeatability of NCS measurements are broadly
grouped into two categories: inter-tester variability and
intra-tester variability. Inter-tester variability refers to var-
iability of a NCS parameter measured on a single individ-
ual when repeat test measurements are made by two or
more examiners. Intra-tester variability refers to variability
of a NCS parameter when repeat test measurements are
made by a single examiner. It has been suggested that
both types of variability may be minimized with measure-
ment standardization and incorporation of computerized
data acquisition and waveform processing [7]. A recent
study investigating the reliability of computerized NCS
methods in a group of healthy subjects found that the
reproducibility of the NCS parameters compared favora-
bly with that from traditional electromyography laborato-
ries [8].
The objective of the present study is to quantify the relia-
bility of nerve conduction parameters derived entirely
from computer based waveform acquisition and cursor
assignments for both symptomatic and asymptomatic
subjects. The goals of this study are to evaluate the overall
repeatability of NCS parameters and to determine the rel-
ative contributions of test variability sources. The out-
come of this study may enhance the design of future NCS
instrumentation and facilitate the interpretation of NCS
measurements in clinical applications.
Methods
Subject selection
Study subjects were recruited by advertisements at local
senior centers and health clubs, by direct inquiry of volun-
teers participating in ongoing but unrelated clinical stud-
ies, and by word of mouth of those participating in the
study. All subjects volunteered for the study and provided
written informed consent. The single inclusion criterion
was age 18-80 years. Women were excluded from partici-
pating if they were pregnant or nursing, as were individu-
als with implanted electronic medical devices. Based on
responses to a symptom questionnaire administered at
the start of the first testing session, a board certified neu-
rologist (EAL) classified subjects using a four point symp-
tom scale (0 = asymptomatic, 4 = severe symptoms). The
neurologist was blinded to the electrodiagnostic data
when classifying subjects. The study was approved and
monitored by an independent review board (Copernicus
Group, Cary, NC).
Nerve conduction studies
The median, ulnar, deep peroneal, posterior tibial, and
sural nerves were evaluated bilaterally in each subject at
two test sessions 3-7 days apart. Within each session,
nerves were tested twice within about 10 minutes. The
same technician performed all testing. During the second
test session, the technician had no access to the initial test
session's results. All of the measurements were performed
using a FDA approved commercial NCS/EMG instrument
(ADVANCE™, NeuroMetrix, Inc., Waltham, MA). Tests
were performed in a non-electrically shielded outpatient
examining room with typical sources of electromagnetic
interference (e.g., personal computers, 120 VAC wiring)
present. Stimulating and recording electrode placement
was standardized through use of integrated stimulation
and recording electrodes (NeuroMetrix, Inc.) designed for
use with specific nerves. The electrodes and recording
methods have been described previously [9-11]. Appen-
dix A provides a summary of the electrode configurations,
stimulation and recording sites, and recording tech-
niques.
Nerve conduction parameters
Computerized algorithms embedded in the instrument
controlled stimulus intensity, data acquisition, waveform
cursor assignment, and generation of motor, F-wave and
sensory nerve conduction parameters. Although the test-
ing instrument allows full control over all aspects of stim-
ulation, data collection, and waveform analysis, the
operator was restricted from modifying data collection,
waveform cursors, and measurement values. The reported
parameters were stratified into primary and secondary
nerve conduction parameters. Secondary parameters are
nerve conduction measurements which may not be used
routinely in clinical settings despite having been shown to
be useful in some clinical studies. These include CMAP
duration and area, F-wave chronodispersion and persist-
ence, F-wave/CMAP amplitude ratio, and SNAP duration.
While both were analyzed, only the primary parameters
frequently utilized in routine clinical settings are reported
herein for brevity. They include motor latencies, motor
conduction velocity (CV), compound muscle actionBioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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potential (CMAP) amplitude, F-wave latencies (mini-
mum, mean, and maximum), sensory latency (DSL), sen-
sory CV, and sensory nerve action potential (SNAP)
amplitude. Motor latency is measured from stimulus
onset to the initial deflection of the CMAP (i.e., negative
peak onset). CMAP amplitude is measured from baseline
to the negative peak. Ulnar nerve motor CV across the
elbow is determined by dividing the distance between the
below and above elbow cathode stimulation locations by
the time difference between the corresponding below and
above elbow motor latencies. The DSL is measured from
stimulus onset to the initial negative peak of the SNAP.
The SNAP amplitude is measured from negative to posi-
tive peak. Sensory CV was calculated only for the sural
nerve.
Due to the probabilistic nature of F-wave generation, an F-
wave may not be recordable following every stimulus.
When a measurable F-wave is detected for the trace, F-
wave onset latency is assigned. F-wave onset latency is
defined as the time difference between stimulus onset and
the onset of the detectable F-wave. In the upper extremity,
a maximum of 10 F-waves or 12 F-wave traces were col-
lected. In the lower extremity, a maximum of 20 F-waves
were collected with a maximum of 40 (deep peroneal)
and 24 (posterior tibial) traces. The F-wave mean latency
is the arithmetic mean of all individual F-wave onset
latencies. The F-wave maximum latency is defined as the
95th percentile of the ensemble of individual F-wave onset
latencies. The F-wave minimum latency is defined as the
5th percentile of the ensemble of individual F-wave onset
latencies. F-wave latency parameters are not reported if
fewer than three F-wave onset latencies are available (five
for tibial F-waves) as the parameters are not statistically
robust.
Temperature compensation of raw data was performed by
the instrument based on previously determined tempera-
ture correction factors [12]. Reference temperatures for
compensation purposes were 32°C for median and ulnar
nerves, 30°C for peroneal and tibial nerves, and 28°C for
sural nerves. For example, if the skin temperature meas-
urement from the digital thermometer embedded in the
integrated electrode is 31°C for a median sensory nerve
and the temperature compensation factor is -0.138 ms/
°C, then a raw DSL of 4.0 ms will be compensated to 4.0
- (-0.138)*(31-32) = 3.862 ms. Repeatability analyses
were performed on the data set with and without temper-
ature compensation.
Valid results were not obtained for all parameters in every
test due to technical issues such as excessive environmen-
tal noise, severe stimulus artifact, and poor signal quality.
These technical issues were identified prospectively by the
instrument as part of its normal operation [7] and are
therefore not treated as outliers. When these technical
issues were detected, the instrument did not analyze the
waveforms, and nerve conduction values were not
reported.
Outliers excluded from analyses
A small number of reported measurements are identified
as outliers based on a retrospective review of the data and
they are grouped into three categories below. Primary
analyses were performed on the temperature-compen-
sated data set with Category I and II outliers removed.
However, analyses were also carried out on the data set
with all three category outliers excluded.
Category I outliers
Test-retest values could not be compared because the
recording methodology varied between the two tests. This
occurred with sural nerve testing due to two possible dis-
tances (10 cm and 14 cm) between stimulation and detec-
tion electrodes, depending on the instrument's selection
of the proximal or distal pair of recording electrodes.
Although the individual parameter values were valid in
these cases, they could not be used to assess measurement
reproducibility.
Category II outliers
During routine instrument operation, certain waveform
cursor patterns are suggestive of unreliable waveform cur-
sor assignments. For example, if the instrument could not
assign CMAP duration cursor, the instrument operator is
alerted to review all parameters associated with the CMAP
waveform. In this study, parameters associated with wave-
forms having incomplete cursor assignments were
excluded to eliminate subjectivity in operator's decision.
Category III outliers
During normal instrument operation, cursor assignments
for waveforms are displayed in real-time. The operator is
expected to review all cursor assignments and to correct
any inaccurate cursor assignments to ensure accuracy of
the NCS results. A retrospective analysis of all waveform
cursor assignments was conducted by one of the authors
(XK), and a number of these assignments were deter-
mined to be incorrect. These incorrect cursor assignments
are primarily due to artifact contaminating the wave-
forms. The study operator was restricted from correcting
any inaccurate cursor assignments in order to highlight
the performance of instrument automation in this study.
Statistical methods
The primary study outcome is the variance component
analyses. A nested analysis of the variance model was used
to perform a variance component analysis [13]. The two
key outcome measures were within-session variance and
between-session variance. The former quantifies theBioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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short-term variation in instrument measurements where
all controllable sources of variation are minimized. The
latter quantifies the variation between tests performed 3-
7 days apart with distinct electrode placements. In this
instance, sources of variability independent of the instru-
ment were present and included differences in electrode
placement and physiological changes which had occurred
between the two sessions. Between-session-test variance
quantifies the variation between two tests performed in
two different sessions. The between-session-test variance
is calculated as the sum of within-session variance and
between-session variance. The square root of the variance,
which has the same units as the measurements them-
selves, was reported for determination of the clinical rele-
vance of these results. The within-session, between-
session, and between-session-test coefficient of variation
(CoV, standard deviation divided by the mean) was deter-
mined for each nerve parameter.
Additional statistical measures include the intraclass cor-
relation coefficient (ICC) and relative intertrial variation
(RIV). RIV measures the difference of repeat measure-
ments as a percentage of their mean. For each parameter
type, the 5th and 95th percentile of the RIV values are
reported as RIV interval [14]. These statistics were calcu-
lated for pairs of tests either within a session or between
two sessions. The between-session test-retest pairs were
cascaded for the four possible combinations (i.e., Test 1
(T1) of Session 1 (S1) pairs with T1 of S2, T1S1 paired
with T2S2, T2S1 paired with T1S2, and T2S1 paired with
T2S2).
Results
Subject characteristics
A total of 30 subjects (15 female) participated in this
study. One (female) did not complete the study and was
excluded from further data analysis. The demographics of
the 29 subjects are listed in Table 1. Their ages range from
22 to 77 years (mean 50.0, standard deviation (SD) 17.5
years). The mean body mass index is 25.8 (SD 5.4) with
six patients obese (BMI > 30 kg/m2). Twenty-five subjects
(86%) had symptoms, and eleven subjects (38%) had a
symptom grade of 3 or greater. Twelve subjects reported
occasional or frequent tingling or numbness in extremi-
ties (arm, hand, leg, and/or foot); in six of them, the
symptoms extended beyond the fingers or toes to involve
the hand/forearm or foot/lower leg. Eighteen subjects
reported having low back pain, and nine had neuropathic
pain.
Measurements included and excluded
Measurements of 110 nerve conduction parameters (56
primary parameters and 54 secondary parameters) were
attempted for each test on a given subject. The tests were
repeated once at each of the two sessions, yielding a max-
imum of 440 measurements per subject. Therefore,
among the 29 subjects the maximum possible number of
measurements was 12760. A total of 11961 measure-
ments were reported by the instruments, leading to an
overall measurement yield of 93.7%. The 799 measure-
ments not reported were not outliers because the instru-
ment did not provide any output values prospectively. F-
wave parameters, particularly from the median and pero-
neal nerves, accounted for the majority of unreported
measurements (540 or 67.6%). Twenty-eight (28) meas-
urements (from 6 sural nerves) were excluded as category
I outliers and 24 measurements (from 5 nerves) were
excluded as category II outliers. Primary analyses were
based on a data set with category I and II outliers excluded
and therefore the rate of retrospective data exclusion was
0.43% (52/11961). Thirty-nine (39) measurements (from
8 nerves) were classified as category III outliers. Results
mirroring the primary analyses are presented in Appendix
B, computed after exclusion of all outliers (91). In this
case, the rate of retrospective outlier removal was 0.76%
(91/11961).
Results of statistical analyses
Variance component analysis results are presented in
Table 2 for temperature compensated NCS parameters
with category I and II outliers excluded. The standard devi-
ations of the parameters attributable to individual sub-
ject/nerve; test session; and tests within a session are
calculated in addition to overall parameter standard devi-
ation. The CoVs are tabulated for variation attributable to
sessions and tests. Results for F-wave latency parameters
are also listed separately for upper (median and ulnar)
and lower (peroneal and tibial) extremity nerves as their
mean values differ significantly. Variance component
analyses were repeated for the 11 subjects with a symptom
Table 1: Demographic characteristics of subjects (n = 29)
Gender Age (Yr) Height (cm) BMI (kg/m2) Symptom Grade Days between Sessions
Mean 48%* 50.0 170.3 25.8 2.1 5.5
Standard Deviation - 17.5 7.7 5.4 1.3 1.4
Minimum - 22.0 157.5 15.9 0 3
Maximum - 77.0 185.4 44.1 4 7
* Percentage of female subjects.BioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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grade of 3 or greater and the results for the sub-group are
presented in Table 3.
Analyses were also carried out for each nerve type and the
CoVs for between-session-test variation are summarized
in Table 4 for commonly measured NCS parameters. The
ICC and RIV are tabulated in Table 5 for tests within each
session and across two sessions. The ICCs are all greater
than 0.95 for within session measurements. Additional
ICC results are presented by nerve type in Table 4 for NCS
parameters with contribution from more than one nerve.
The between-session RIV intervals of mean FWL are [-
5.6%, 5.3%] for median nerves, [-7.4%, 4.6%] for ulnar
nerves, [-4.6%, 10.0%] for peroneal nerves, and [-6.7%,
5.7%] for tibial nerves. The RIV intervals of SNAP ampli-
tude are [-34.3%, 28.9%] for median nerves, [-25.5%,
25.7%] for ulnar nerves, and [-79.5%, 152.5%] for sural
nerves.
Table 2: Variance component analyses of nerve conduction parameters for all 29 subjects
Standard Standard Deviation Coefficient of Variation
Parameter Count Mean Deviation Nerve Session Test Session Test Session-Test
Latency
DML 910 3.49 0.82 0.79 0.24 0.12 6.8% 3.5% 7.6%
Latency Elbow 450 7.65 1.43 1.39 0.35 0.06 4.5% 0.8% 4.6%
DSL 653 3.31 0.72 0.64 0.29 0.15 8.7% 4.6% 9.8%
Conduction Velocity (CV)
Ulnar CV Elbow 221 50.78 7.08 6.67 2.02 1.35 4.0% 2.7% 4.8%
Sural CV 200 37.12 3.80 3.45 1.59 0.75 4.3% 2.0% 4.7%
F-wave Latency (FWL), All Nerves
Mean FWL 832 40.15 12.86 13.15 0.96 1.41 2.4% 3.5% 4.2%
Minimum FWL 801 37.92 12.17 12.63 1.16 1.53 3.1% 4.0% 5.1%
Maximum FWL 801 42.41 14.13 14.51 0.03 2.19 0.1% 5.2% 5.2%
Median/Ulnar Nerve FWL
Mean FWL 421 28.50 3.14 2.97 0.64 0.71 2.3% 2.5% 3.4%
Minimum FWL 421 27.43 2.95 2.74 0.71 0.76 2.6% 2.8% 3.8%
Maximum FWL 421 30.29 3.63 3.27 0.82 1.34 2.7% 4.4% 5.2%
Peroneal/Tibial Nerve FWL
Mean FWL 411 52.09 6.54 6.63 1.16 1.88 2.2% 3.6% 4.2%
Minimum FWL 380 49.54 6.75 7.00 1.50 2.10 3.0% 4.2% 5.2%
Maximum FWL 380 55.84 7.92 7.77 0.00 2.79 0.0% 5.0% 5.0%
Amplitude
CMAP Amplitude 910 5.17 2.66 2.54 0.81 0.25 15.6% 4.8% 16.3%
CMAP Amplitude Elbow 450 5.65 1.97 1.77 0.83 0.29 14.8% 5.1% 15.6%
SNAP Amplitude 668 26.94 19.12 18.33 4.51 2.86 16.8% 10.6% 19.8%
Measurement units:
é Latency parameters are in milliseconds.
é Conduction velocities are in meters per second.
é CMAP amplitude is in millivolts.
é SNAP amplitude is in microvolts.
F-wave latency results are also presented separately for median/ulnar nerve group and peroneal/tibial nerve group as they have significantly different 
mean values.
Standard deviations attributable to nerves (i.e., variation among different subjects) are highest, followed by standard deviations attributable to 
variation between two sessions (separated by 3-7 days) for most parameters.
Standard deviations attributable to test variation are generally the lowest, with the exception of F-wave latency.BioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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Without temperature compensation, the within-session
CoVs were about the same as that with temperature com-
pensation for all parameters. However, the between-ses-
sion CoVs increased to 9.5% for DML (compared to 6.8%
with compensation), 9.8% for DSL (8.7% with compen-
sation), and 6.6% for sural CV (4.3% with compensa-
tion). Similarly, the ICCs for between session tests
decreased to 0.83 for DML (from 0.90 with compensa-
tion), 0.83 for DSL (no change), and 0.63 for sural CV
(0.77 with compensation).
Thirty-nine (39) category III outliers were included in the
analysis results presented in Tables 2, 3, 4 and 5. They
were associated with incorrect automated cursor assign-
ments that were readily identifiable and correctable.
Excluding these outliers reduced the between-session-test
Table 3: Variance component analyses of nerve conduction parameters for subjects with symptom grade > 2
Standard Standard Deviation Coefficient of Variation
Parameter Count Mean Deviation Nerve Session Test Session Test Session-Test
Latency
DML 345 3.62 0.95 0.34 0.31 0.12 8.7% 3.3% 9.3%
Latency Elbow 168 7.93 1.56 0.48 0.48 0.05 6.0% 0.7% 6.0%
DSL 246 3.48 0.94 0.47 0.42 0.22 12.0% 6.2% 13.5%
Conduction Velocity (CV)
Ulnar CV Elbow 80 48.49 7.18 2.94 2.8 0.91 5.8% 1.9% 6.1%
Sural CV 73 35.59 4.49 2.1 1.93 0.82 5.4% 2.3% 5.9%
F-wave Latency (FWL), All Nerves
Mean FWL 311 40.58 13.17 2.14 1.37 1.64 3.4% 4.0% 5.3%
Minimum FWL 301 38.38 12.59 2.28 1.42 1.78 3.7% 4.6% 5.9%
Maximum FWL 301 42.73 14.06 2.2 0.4 2.16 0.9% 5.1% 5.1%
Median/Ulnar Nerve FWL
Mean FWL 163 29.33 3.86 1.27 1.01 0.78 3.4% 2.7% 4.3%
Minimum FWL 163 28.15 3.51 1.34 1.12 0.73 4.0% 2.6% 4.8%
Maximum FWL 163 31.27 4.51 2.02 1.26 1.58 4.0% 5.0% 6.4%
Peroneal/Tibial Nerve FWL
Mean FWL 148 52.97 7.37 2.79 1.62 2.28 3.1% 4.3% 5.3%
Minimum FWL 138 50.46 7.83 3.07 1.67 2.57 3.3% 5.1% 6.1%
Maximum FWL 138 56.26 8.26 2.53 0 2.53 0.0% 4.5% 4.5%
Amplitude
CMAP Amplitude 345 5.15 2.86 0.74 0.7 0.25 13.5% 4.8% 14.3%
CMAP Amplitude Elbow 168 5.16 1.89 0.72 0.67 0.26 13.0% 5.0% 13.9%
SNAP Amplitude 255 24.61 21.73 5.85 5.42 2.22 22.0% 9.0% 23.8%
Measurement units:
é Latency parameters are in milliseconds.
é Conduction velocities are in meters per second.
é CMAP amplitude is measured in millivolts.
é SNAP amplitude is measured in microvolts.
F-wave latency results are also presented separately for median/ulnar nerve group and peroneal/tibial nerve group as they have significantly different 
mean values.
Standard deviations attributable to nerves (i.e., variation among different subjects) are highest, followed by standard deviations attributable to 
variation between two sessions (separated by 3-7 days) for most parameters.
Standard deviations attributable to test variation are generally the lowest, with the exception of F-wave latency.BioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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Table 4: Repeatability performance measures by nerve type
Parameter Median Ulnar Peroneal Tibial Sural Overall
CoV for between-session-test variation
DML 5.9% 4.1% 8.1% 9.5% - 7.6%
DSL 8.0% 14.2% - - 4.5% 9.8%
Mean FWL 3.7% 2.9% 5.0% 3.8% - 4.2%
Minimum FWL 4.1% 3.5% 4.6% 5.8% - 5.1%
Maximum FWL 5.2% 5.0% 5.8% 4.0% - 5.2%
CMAP Amplitude 7.5% 16.3% 18.7% 23.6% - 16.3%
SNAP Amplitude 16.8% 18.3% - - 30.8% 19.8%
ICC for between-session tests
DML 0.93 0.83 0.78 0.53 - 0.90
DSL 0.88 0.55 - - 0.83 0.83
Mean FWL 0.93 0.91 0.83 0.94 - 0.98
Minimum FWL 0.91 0.87 0.85 0.85 - 0.98
Maximum FWL 0.85 0.79 0.81 0.96 - 0.98
CMAP Amplitude 0.93 0.77 0.90 0.90 - 0.91
SNAP Amplitude 0.92 0.83 - - 0.76 0.92
Table 5: ICC and RIV interval for nerve conduction study parameter repeatability
Within Session Tests Between Session Tests
ICC RIV ICC RIV
Latency
DML 0.98 [-3.6%, 7.2%] 0.90 [-15.9%, 13.1%]
Latency Elbow 1.00 [-1.3%, 1.9%] 0.94 [-8.3%, 10.0%]
DSL 0.96 [-3.8%, 4.3%] 0.83 [-9.1%, 14.5%]
Conduction Velocity (CV)
Ulnar CV Elbow 0.97 [-5.3%, 4.5%] 0.89 [-12.2%, 8.3%]
Sural CV 0.96 [-4.7%, 3.2%] 0.77 [-9.6%, 12.8%]
F-Wave Latency (FWL)
Mean FWL 0.99 [-3.8%, 4.6%] 0.98 [-6.1%, 5.7%]
Minimum FWL 0.98 [-6.1%, 5.8%] 0.98 [-9.1%, 7.7%]
Maximum FWL 0.98 [-7.6%, 7.6%] 0.98 [-9.0%, 9.3%]
Amplitude
CMAP Amplitude 0.99 [-9.2%, 17.7%] 0.91 [-48.4%, 37.6%]
CMAP Amplitude Elbow 0.98 [-9.0%, 10.9%] 0.83 [-34.4%, 23.4%]
SNAP Amplitude 0.98 [-11.9%, 12.5%] 0.92 [-46.0%, 31.5%]BioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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CoV to 6.9% for DML, 6.3% for DSL, and 15.4% for SNAP
amplitude. The ICCs for between session tests increased to
0.92 for DML, 0.93 for DSL, and 0.95 for SNAP ampli-
tude. Complete results mirroring those in Tables 2, 3, 4
and 5 can be found in Tables 6, 7 and 8.
Figure 1 presents a scatter plot of median nerve SNAP
amplitude for Test 2 of the two study sessions. Filled cir-
cles are the SNAP results from subjects who had self-
reported symptoms of frequent hand/arm pain or tin-
gling. The ICC is 0.95 for nerves without stated symptoms
(i.e., open circles) and 0.93 for nerves with stated symp-
toms (filled circles).
Discussion
Repeat nerve conduction measurements do not generate
numerically identical values because they are influenced
by sources of variation. These include use of disparate
equipment, differences in placement of stimulating and
recording electrodes, and manual assignments of wave-
form cursors. The present study controlled for several of
these potential sources of variation. The same instrument
was used throughout the study. For tests within each ses-
sion, the effect of electrode placement variation was con-
trolled through the use of nerve specific integrated
electrodes that remained in position between tests; addi-
tionally, manual editing of waveform cursors was not per-
mitted. However, notwithstanding these controls, other
sources of variation could not be mitigated and may have
impacted within-session test-retest repeatability. These
sources of variation included amplifier noise, Johnson
noise, 60 Hz and other sources of electrical interference,
short term changes in the electrode to skin interface, small
unavoidable patient movements, short term physiological
noise due to changes in blood flow and perspiration, and
random motor neuron sampling during elicitation of F-
waves. For between-session testing, the same within-ses-
sion controls were in effect, with the exception that a new
electrode array was applied.
Although functionality was provided by the instrument
used in this study to perform real-time data acquisition
control and manual editing of computer cursor assign-
ments, this functionality was not utilized. As such, the
study design eliminated the uncertainty associated with
manual waveform cursor assignment. Therefore, the relia-
bility of nerve conduction parameters in this study is
exclusively based on computer based data acquisition and
waveform cursor assignments. Retrospective manual
review of all waveforms and computer cursor assignments
identified only 39 out of 11961 cursor assignments need-
ing corrections. As instrument operators are expected to
review waveforms and cursor assignments during normal
operations, repeatability performance of the instrument
should be better than that reported in Tables 2, 3, 4 and 5.
Indeed, results in Appendix B confirmed the performance
improvement when these 39 outliers were removed from
the analyses. For example, the ICC for between-session
tests increased to 0.93 (from 0.83) for DSL and to 0.95
(from 0.92) for SNAP amplitude. Similarly, the between-
session-test CoV was reduced by 36% (from 9.8% to
6.3%) and 22% (from 19.8% to 15.4%) respectively for
DSL and SNAP amplitude.
Analysis of variance results quantify the contribution of
various sources to NCS variability between measure-
Table 6: Repeatability performance measures by nerve type with category I-III outliers removed
Parameter Median Ulnar Peroneal Tibial Sural Overall
CoV for between-session-test variations
DML 5.9% 4.1% 7.6% 7.8% - 6.9%
DSL 7.6% 4.5% - - 4.5% 6.3%
Mean FWL 3.7% 2.9% 5.0% 3.8% - 4.2%
Minimum FWL 4.1% 3.5% 4.6% 5.8% - 5.1%
Maximum FWL 5.2% 5.0% 5.8% 4.0% - 5.2%
CMAP Amplitude 7.5% 16.3% 18.6% 23.7% - 16.3%
SNAP Amplitude 13.4% 11.3% - - 30.8% 15.4%
ICC for between-session tests
DML 0.93 0.83 0.81 0.67 - 0.92
DSL 0.89 0.90 - - 0.83 0.93
Mean FWL 0.93 0.91 0.83 0.94 - 0.98
Minimum FWL 0.91 0.87 0.85 0.85 - 0.98
Maximum FWL 0.85 0.79 0.81 0.96 - 0.98
CMAP Amplitude 0.93 0.77 0.90 0.90 - 0.90
SNAP Amplitude 0.95 0.97 - - 0.76 0.95BioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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ments. The between-test CoV measures the variation in
NCS measurements and therefore represents the neuro-
physiological variability inherent in nerve conduction
testing and the variability attributable to the instrument in
absence of operator intervention. In the present study,
motor and sensory latencies and conduction velocities all
have CoV values at or below 5%. CMAP and SNAP ampli-
tude parameters have a higher CoV at 5-11%. Low CoV
values between tests within a session (i.e., same electrode
placement and retest within 10 minutes) suggest that the
instrument functioned in a reproducible fashion.
Between-session CoV measures are higher than between-
test CoV. The between-session CoV captures the variability
occurring independent of within-session variation, such
as differences in electrode placement and inter-session
physiological changes. Nevertheless, the CoV are still
below 9% for all latency and CV parameters and around
15% for amplitude parameters. The between-session
Table 7: Variance component analyses of nerve conduction parameters (excluding category I-III outliers)
Standard Standard Deviation Coefficient of Variation
Parameter Count Mean Deviation Nerve Session Test Session Test Session-Test
Latency
DML 904 3.50 0.82 0.80 0.22 0.11 6.2% 3.1% 6.9%
Latency Elbow 450 7.65 1.43 1.39 0.35 0.06 4.5% 0.8% 4.6%
DSL 649 3.29 0.69 0.65 0.19 0.07 5.9% 2.1% 6.3%
Conduction Velocity (CV)
Ulnar CV Elbow 221 50.78 7.08 6.67 2.02 1.35 4.0% 2.7% 4.8%
Sural CV 200 37.12 3.80 3.45 1.59 0.75 4.3% 2.0% 4.7%
F-wave Latency (FWL), All Nerves
Mean FWL 832 40.15 12.86 13.15 0.96 1.41 2.4% 3.5% 4.2%
Minimum FWL 801 37.92 12.17 12.63 1.16 1.53 3.1% 4.0% 5.1%
Maximum FWL 801 42.41 14.13 14.51 0.03 2.19 0.1% 5.2% 5.2%
Median/Ulnar Nerve FWL
Mean FWL 421 28.50 3.14 2.97 0.64 0.71 2.3% 2.5% 3.4%
Minimum FWL 421 27.43 2.95 2.74 0.71 0.76 2.6% 2.8% 3.8%
Maximum FWL 421 30.29 3.63 3.27 0.82 1.34 2.7% 4.4% 5.2%
Peroneal/Tibial Nerve FWL
Mean FWL 411 52.09 6.54 6.63 1.16 1.88 2.2% 3.6% 4.2%
Minimum FWL 380 49.54 6.75 7.00 1.50 2.10 3.0% 4.2% 5.2%
Maximum FWL 380 55.84 7.92 7.77 0.00 2.79 0.0% 5.0% 5.0%
Amplitude
CMAP Amplitude 904 5.19 2.66 2.54 0.81 0.25 15.6% 4.8% 16.3%
CMAP Amplitude Elbow 450 5.65 1.97 1.77 0.83 0.29 14.8% 5.1% 15.6%
SNAP Amplitude 663 26.87 19.02 18.52 3.82 1.61 14.2% 6.0% 15.4%
Measurement units:
é Latency parameters are in milliseconds.
é Conduction velocities are in meters per second.
é CMAP amplitude is measured in millivolts.
é SNAP amplitude is measured in microvolts.
F-wave latency results are also presented separately for median/ulnar nerve group and peroneal/tibial nerve group as they have significantly different 
mean values.
Standard deviations attributable to nerves (i.e., variation among different subjects) are highest, followed by standard deviations attributable to 
variation between two sessions (separated by 3-7 days) for most parameters.
Standard deviations attributable to test variation are generally the lowest, with the exception of F-wave latency.BioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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CoVs are greater than within-session CoVs for all parame-
ters except for F-wave latencies. A higher between-test CoV
for F-wave latency is a direct result of the stochastic nature
of F-waves.
The between-session-test CoV quantifies the total varia-
tion between tests performed 3-7 days apart during two
different sessions (with distinct electrode placements).
Motor and sensory latencies, conduction velocities and F-
wave latency parameters have low between-session-test
CoVs ranging from 4.2% to 9.8%. These results are com-
parable to the reliability of similar parameters obtained in
controlled multi-center clinical trials with central labora-
tory oversight [3,4]. The between-session-test CoV of this
study is a more conservative measure of repeatability than
the between-session CoV in the two benchmark studies, as
the between-session-test CoV captures both between-ses-
sion and between-test (within a session) variation. In this
study, the motor and sensory amplitudes have between-
session-test CoVs that range from 15.6 to 19.8%. These
results are consistent with between-session CoV results in
[3], which were 9-16%; and better than sensory amplitude
between-session CoV results reported in [4], which were
approximately 50%.
F-wave latency parameters exhibited similar repeatability
among the studied nerves. As in other studies, the DML
and CMAP amplitude parameters in this study have supe-
rior repeatability for upper extremity nerves compared to
lower extremity nerves. A study by Bril and colleagues [3]
showed that the CoVs for peroneal DML and CMAP
amplitude were about 25% higher than those for the cor-
responding median nerves. A similar increase in DML is
seen in this study but the CoV increase in CMAP ampli-
tude is larger. Greater peroneal and tibial CMAP ampli-
tude variability may be due to the small recording
electrode sizes (surface areas < 2 cm2) used in this study
[15]. For sensory responses, ulnar DSL and SNAP were
disproportionably affected by the outliers and the per-
formance levels are comparable between the median and
ulnar nerves when category III outliers are excluded (see
Table 6). Compared to the median nerve, the sural SNAP
amplitude in this study exhibited lower reliability (ICC of
0.92 for median versus 0.76 for sural), similar to data
(ICC of 0.83 for median versus 0.77 for sural) reported
elsewhere [14].
When ranked by the CoV, F-wave latencies have the best
reproducibility (≤ 5%), followed by conduction velocity
and latency parameters (<10%). Amplitudes have lower
reproducibility; however, the CoVs are still below 20%.
This repeatability hierarchy is consistent with the multi-
center study by Kohara and colleagues in which they con-
cluded that the minimum F-wave latency was the most
reproducible nerve conduction measure for assessing dia-
betic neuropathy using manual electrodiagnostic meth-
Table 8: ICC and RIV interval for nerve conduction study parameter repeatability with category I-III outliers removed
Within Session Tests Between Session Tests
ICC RIV ICC RIV
Latency
DML 0.98 [-3.5%, 7.2%] 0.92 [-15.3%, 12.9%]
Latency Elbow 1.00 [-1.3%, 1.9%] 0.94 [-8.3%, 10.0%]
DSL 0.99 [-3.6%, 4.1%] 0.93 [-8.6%, 14.3%]
Conduction Velocity (CV)
Ulnar CV Elbow 0.97 [-5.3%, 4.5%] 0.89 [-12.2%, 8.3%]
Sural CV 0.96 [-4.7%, 3.2%] 0.77 [-9.6%, 12.8%]
F-Wave Latency (FWL)
Mean FWL 0.99 [-3.8%, 4.6%] 0.98 [-6.1%, 5.7%]
Minimum FWL 0.98 [-6.1%, 5.8%] 0.98 [-9.1%, 7.7%]
Maximum FWL 0.98 [-7.6%, 7.6%] 0.98 [-9.0%, 9.3%]
Amplitude
CMAP Amplitude 0.99 [-9.1%, 17.5%] 0.90 [-47.8%, 37.1%]
CMAP Amplitude Elbow 0.98 [-9.0%, 10.9%] 0.83 [-34.4%, 23.4%]
SNAP Amplitude 0.99 [-11.5%, 12.4%] 0.95 [-42.7%, 30.0%]BioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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ods [14]. A study by Bird and colleagues [4] showed a
similar pattern of repeatability ranking for various NCS
parameters using data from a multi-center trial: The CoV
was lowest for F-wave latency (8-11%), followed by
motor and sensory conduction velocity (8-12%), and
finally sensory amplitude (52-53%).
Uniformly high intraclass correlation coefficients (ICC)
are observed for all NCS parameters when two tests within
a session are compared. When tests from different ses-
sions are compared, the ICC is highest for F-wave latencies
(0.98), and slightly lower for motor and sensory latencies
(0.83-0.94), amplitudes (0.83-0.92), and conduction
velocities (0.77-0.89). These results are comparable to the
results reported in other repeatability studies [4,14,16].
For example, the ICC for median nerve minimum F-wave
latency is 0.91 in this study while an ICC of 0.93-0.94 was
reported for the minimum F-wave latency in the study by
Kohara et al. [14] and 0.87-0.90 in the study of Bird et al.
[4]. In this study, the lowest amplitude ICC is 0.76 for the
sural nerve. Similar sural amplitude ICC values were
reported as 0.76-0.80 in [4], 0.77 in [14], and 0.74 in [16].
RIV intervals were reported as a repeatability metric in two
other studies [14,16]. F-wave latency parameters have the
narrowest RIV intervals among all NCS parameters in the
present study, similar to the results from the aforemen-
tioned studies. The RIV intervals of mean F-wave latencies
are narrower than those in the study of Pinheiro et al. for
the ulnar and tibial nerves [16]. CMAP and SNAP ampli-
tudes have the widest RIV intervals in the present study,
matching the results reported in the other two studies. For
example, the RIV interval for tibial CMAP amplitude is [-
68.5%, 46.2%], compared with [-89%, 75%] in the Pin-
heiro study, and [-35%, 40%] in [14].
Skin temperature changes have a predictable effect on
motor and sensory latencies [17]; however, control of skin
temperature is often difficult to achieve. In this study,
rather than warming or cooling extremities to achieve uni-
form skin temperature, the impact of skin temperature
was mitigated by mathematical compensation within a
predetermined range. Temperature compensation does
not have a material impact on test-retest repeatability
within a session as measured by between-test CoV since
any temperature variation between the two tests 10-
minute apart are negligible. However, temperature com-
Scatter plot of median nerve SNAP amplitude measured in two study sessions (3-7 days apart) Figure 1
Scatter plot of median nerve SNAP amplitude measured in two study sessions (3-7 days apart). Filled circles are 
from subjects who had complaint of frequent hand/arm pain or tingling. The intra-class correlation coefficient (ICC) is 0.95 for 
open circles (nerves from subjects without frequent hand/arm pain or tingling) and 0.93 for filled circles (nerves from subjects 
with frequent hand/arm pain or tingling).
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pensation improves reproducibility for tests between two
sessions 3-7 days apart, as the temperature variation can
be significant. The CoVs of the DML and DSL decrease by
28.4% and 11.2% respectively, with temperature compen-
sation. The sural conduction velocity CoV decreases by
34.8%, and mean F-wave latency CoVs decreases by
14.3%. Similar improvements are noted using ICC and
RIV intervals.
A total of 799 of 12760 (6.3%) NCS measurements were
prospectively rejected by the electrodiagnostic instru-
ment. These rejected measurements are not outliers as
they were not processed and reported by the instrument.
The reasons for these rejections were poor signal quality
or artifact interfering with the evoked response. This rate
of rejection is comparable to the rate observed in control-
led studies of nerve conduction reproducibility with cen-
tral laboratory oversight. Bril and colleagues reported an
average trace rejection rate of 6.3 to 8.7% [3]. In another
study with similar design, Bird and colleagues reported a
trace rejection rate of 4% [4].
During a retrospective review of the data, 52 measure-
ments were flagged as unsuitable for repeatability per-
formance evaluation (category I and II outliers defined in
Method section). An additional 39 measurements were
identified as outliers due to inaccurate cursor assignments
(category III outliers). Because this study was designed to
assess the reproducibility of computer-generated nerve
conduction parameters without human intervention
(although such intervention is possible with the instru-
ment used), the inaccurate cursor assignments affecting
39 NCS parameters were left unchanged rather than man-
ually corrected. The rate of outliers in this study (39/
11961, 0.33%) is low compared to the rate of trace correc-
tions reported in the benchmark studies; 34.3 - 38.2% in
[3]; and 19% in [4]. In practice, outliers are expected to be
corrected manually during operator review of NCS wave-
forms, and these corrections should lead to an improve-
ment in repeatability performance metrics.
Conclusion
In this study the reproducibility of nerve conduction
parameters is assessed quantitatively based on data
acquired by an electrodiagnostic instrument using com-
puter based waveform cursor assignment. The results are
benchmarked against those from nerve conduction repro-
ducibility studies in which the nerve conduction measure-
ments were performed manually with central laboratory
review [3,4,14,16]. The reliability of motor and sensory
latencies, conduction velocities, F-wave latencies, and
motor and sensory amplitudes are comparable to the
results obtained in the benchmark studies. Furthermore,
the ranking of reliability, whereby F-wave latencies have
the best reproducibility and amplitudes the worst, is also
consistent with the benchmark studies. The study demon-
strates that nerve conduction parameters acquired with
modern electrodiagnostic instruments are highly repeata-
ble. The repeatability of nerve conduction measurements
make them ideal candidates for longitudinal tracking of
peripheral nerve function, such as in monitoring neuro-
pathic disease progression, assessing the efficacy of inter-
ventions in clinical trials, and detecting peripheral
neurotoxicity.
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Appendix A. Description of Nerve Specific 
Electrodes and Recording Techniques
The electrodes used in this study are commercially availa-
ble, pre-fabricated, nerve specific, surface electrode arrays
(NeuroMetrix, Inc., Waltham, MA). In addition to stimu-
lating (cathode and anode) and recording (active, inac-
tive, and reference) electrodes, each nerve specific
electrode array (NSE) incorporates a digital thermometer,
a unique digital identifier, printed electrical traces, and a
keyed connector.
Median NSE
When a median NSE is properly affixed to the patient's
skin utilizing anatomic landmarks, the stimulation cath-
ode is located over the median nerve at the midline volar
wrist, 3.0 centimeter (cm) proximal to the distal wrist
crease. The 2.4 cm by 2.4 cm active recording electrode is
located over the motor point of the abductor pollicis
brevis, while the inactive recording electrode is positioned
over the interphalangeal joint of the thumb. Concurrent
with acquisition of motor and F-wave responses, an antid-
romic sensory response is recorded from the middle finger
(digit 3) using ring electrodes. The active electrode is
located over the proximal interphalangeal (PIP) joint,
with the inactive electrode 3.0 cm more distal. Inter-elec-
trode distances are measured from center to center.
Ulnar NSE
When an ulnar NSE is properly affixed to the patient's skin
utilizing anatomic landmarks, the stimulation cathode is
located over the ulnar nerve at the medial volar wrist, 3.0
cm proximal to the distal wrist crease. The 1.0 cm by 2.0
cm active recording electrode is located over the motor
point of the abuductor digiti minimi, while the inactive
recording electrode is positioned over the lateral volarBioMedical Engineering OnLine 2009, 8:33 http://www.biomedical-engineering-online.com/content/8/1/33
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wrist. Concurrent with acquisition of motor and F-wave
responses, an antidromic sensory response is recorded
from the small finger (digit 5) using ring electrodes. The
active electrode is located over the proximal interphalan-
geal (PIP) joint, with the inactive electrode 2 cm more dis-
tal. Proximal ulnar motor responses (CMAPs) are elicited
by stimulating the nerve above and below the elbow. The
distance between the above and below elbow stimulation
cathodes is fixed at 10.5 cm [18], and stimulation is
applied at the below elbow cathode prior to the above
elbow cathode. An arm support fixture is used during
proximal ulnar nerve stimulation to ensure arm flexion of
110 degrees measured between the upper arm and fore-
arm [18,19]. An electronic adapter links the proximal
stimulation sites to the distal stimulation and recording
integrated electrode.
Peroneal NSE
When a peroneal NSE is properly affixed to the patient's
skin utilizing anatomic landmarks, the stimulation cath-
ode is located over the deep peroneal nerve where the lat-
eral margin of the tibia intersects the intermalleolar line.
The CMAP and F-waves are recorded using two pairs of
interspersed recording electrodes placed along a line
between the lateral malleolus and the third toe, over the
extensor digitorum brevis muscle. Two pairs of electrodes
are utilized to enable a four electrode motor response
scanning capability. The four electrodes are of equal size
(0.7 cm by 2.7 cm). The distance between the two elec-
trodes of each pair is 2.5 cm. Motor responses from both
detector pairs are compared to determine which active
electrode is directly over the motor point [20]. Subse-
quent acquisitions of motor response parameters are
made from this electrode, with the other electrode of the
pair acting as an "inactive" electrode.
Tibial NSE
When a tibial NSE is properly affixed utilizing to the
patient's skin using anatomic landmarks, the stimulation
cathode is located over the posterior tibial nerve just pos-
terior to the medial malleolus. The motor response is
recorded using a detector pair located just distal to the
medial malleolus with electrode size of 0.7 cm by 2.2 cm.
The active electrode is located anterior to the inactive elec-
trode. This detector configuration records the intermedi-
ate/far-field potential from non-moving dipole sources in
tibial innervated foot muscles [21,22]. The resulting
motor response is similar in shape and magnitude to
those recorded directly over abductor hallucis--the muscle
from which the tibial motor response is typically recorded
from [20].
Sural NSE
When a sural NSE is properly affixed to the patient's skin
utilizing anatomic landmarks, the stimulation cathode is
positioned over the sural nerve in the midline lower calf,
while the proximal active electrode is positioned posterior to
the lateral malleolus. A proximal inactive electrode is located
1.5 cm inferior to the active electrode (referencing stand-
ard anatomic position), measured center-to-center. A sec-
ond pair of recording electrodes is positioned inferior to
the lateral malleolus, also with 1.5 cm inter-electrode sep-
aration. All four electrodes are 1.0 cm by 3.5 cm. The two
active electrodes are 4 cm apart. The device analyzes the
antidromic sensory response recorded from the proximal
pair unless the waveform quality is poor, in which case
responses recorded from the distal pair are analyzed.
Appendix B. NCS Repeatability Performance 
with Exclusion of Outliers
During the normal course of operation, the NCS instru-
ment displays waveforms and cursor assignments in real-
time immediately after the waveforms are acquired and
analyzed. The instrument operator is expected to review
the waveforms and manually correct any inaccurate cursor
assignments. The study design eliminated the manual cor-
rection step in order to obtain the reliability of nerve con-
duction parameters derived from data acquired and
analyzed exclusively by a computer. Thirty-nine (39) out
of 11961 cursor assignments were found to be in need of
correction based upon a manual review. With the 39 out-
liers removed, we report the analysis results mirroring
those presented in main text in order to enumerate the
true repeatability performance metrics of the NCS instru-
ment when manual waveform reviews are allowed.
Repeatability analysis results are presented in Tables 6, 7
and 8 for temperature compensated NCS parameters with
category I-III outliers excluded. Table 6 summarizes the
between-session-test CoVs for commonly measured NCS
parameters of each nerve type, together with ICC for the
same parameters. Variance component analysis results are
presented in Table 7. Motor and sensory latencies and
conduction velocities all have between-test CoV values at
or below 5%. CMAP and SNAP amplitude parameters
have a slightly higher CoV at 5-6%. Motor and sensory
latencies, conduction velocities and F-wave latency
parameters have low between-session-test CoVs ranging
from 4.2% to 6.9%. The SNAP amplitude between-ses-
sion-test CoV is reduced to 15.4% from 19.8% when 5
readily identifiable category III outliers (out of 668 tests)
are excluded. The ICC and RIV are tabulated in Table 8 for
tests within each session and across two sessions. The
ICCs are all greater than 0.95 for within session measure-
ments. For between session measurements, the ICCs are
no less than 0.92 for latencies, 0.83 for amplitudes, and
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